CN Patent

CN107848984A — 用于制备麦角硫因化合物的Nα,Nα,Nα‑三烷基组氨酸衍生物

Assigned to Mironova Innovations LLC · Expires 2018-03-27 · 8y expired

What this patent protects

本发明提供了N α ,N α ,N α ‑三烷基组氨酸衍生物化合物及其制备方法。本发明还提供了使用所述化合物制备有用化合物如麦角硫因的方法。

USPTO Abstract

本发明提供了N α ,N α ,N α ‑三烷基组氨酸衍生物化合物及其制备方法。本发明还提供了使用所述化合物制备有用化合物如麦角硫因的方法。

Drugs covered by this patent

indigotindisulfonate-sodium (INDIGOTINDISULFONATE SODIUM)

Patent Metadata

Patent number: CN107848984A
Jurisdiction: CN
Classification: —
Expires: 2018-03-27
Drug substance claim: No
Drug product claim: No
Assignee: Mironova Innovations LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.